Table 1.
Pretreatment CA125 level >35 U/mL in epithelial ovarian cancer. Relationship between histological subtype and FIGO stage
| Histological subtypes | ||||||
|---|---|---|---|---|---|---|
| FIGO Stage | Serous | Endometrioid | Mucinous | Clear Cell | Mixed | Total |
| I | 8/9 | 30/37 | 16/22 | 12/18 | 9/10 | 75/96 |
| 89 % | 81 % | 73 % | 67 % | 90 % | 78 % | |
| 231 U/mL | 137 U/mL | 113 U/mL | 153 U/mL | 305 U/mL | ||
| II | 3/4 | 6/8 | 1/1 | 1/1 | 2/2 | 13/16 |
| 75 % | 75 % | 100 % | 100 % | 100 % | 81 % | |
| 90 U/mL | 281 U/mL | 75 U/mL | 1042 U/mL | 252 U/mL | ||
| III | 116/118 | 35/36* | 6/10 | 11/11* | 27/28 | 195/203 |
| 98 % | 97 % | 60 % | 100 % | 96 % | 96 % | |
| 1255 U/mL | 861 U/mL | 195 U/mL | 415 U/mL | 1182 U/mL | ||
| IV | 137/137* | 13/13 | 4/6 | 7/8 | 10/10 | 171/174 |
| 100 % | 100 % | 67 % | 88 % | 100 % | 98 % | |
| 2005 U/mL | 511 U/mL | 144 U/mL | 376 U/mL | 1240 U/mL | ||
| Total | 264/268 | 84/94 | 27/39*** | 31/38 | 48/50 | |
| 99 % | 89 % | 69 % | 82 % | 96 % | ||
Values indicate the proportion and percentage of patients with abnormal CA125 and the means of pretreatment values of CA125 U/mL. Comparison of proportions (“Z”)
*P < 0.05 versus FIGO stage I; ***P < 0.001 vs serous and P < 0.01 vs. endometrioid total values